The National Institutes of Health (NIH) on Friday made a significant reduction in grants reserved for research institutions, a decision that may significantly impact American higher education.

“Without relief from NIH’s action, these institutions’ cutting-edge work to cure and treat human disease will grind to a halt.” The NIH is the primary source of federal funding for medical ...

Tabak, a dentist and researcher, was appointed as the NIH’s principal deputy director in 2010. His tenure spans four presidential administrations, and includes a nearly two-year stint as the ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

The money supports “the research infrastructure,” said Iwashyna, who relies on NIH funding for research on chronic illnesses, including pneumonia, among the leading causes of hospitalizations ...

The U.S. National Institutes of Health (NIH) is the largest funder of biomedical research in the world, and its grants create the foundation of basic science knowledge on which major health ...

The big losers would include prestigious institutions in conservative states. The NIH, the nation’s top funder of biomedical research, announced on Friday that it would substantially limit ...

The NIH, the largest funder of biomedical research in the U.S., will limit funding for indirect costs to 15%. Indirect costs cover expenses like building maintenance and administrative salaries.

Scientific researchers are concerned after the National Institutes of Health (NIH) abruptly canceled numerous meetings essential to the fellowship and grant approval process earlier this week.

National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...

Within hours, as word of NIH meeting cancellations pinged across the social media platform Bluesky, she realized that this wasn’t only about the opioid research she would be reviewing ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.